Gregory G Westin1, Ehrin J Armstrong2, Usman Javed3, Christopher R Balwanz4, Haseeb Saeed3, William C Pevec5, John R Laird3, David L Dawson5. 1. Division of Vascular and Endovascular Surgery, New York University Medical Center, New York, NY. Electronic address: Greg.Westin@nyumc.org. 2. Division of Cardiology, University of Colorado Denver and VA Eastern Colorado Healthcare System, Denver, CO. 3. Division of Cardiovascular Medicine and the Vascular Center, University of California, Davis Medical Center, Sacramento, CA. 4. Division of Cardiovascular Diseases, University of Kansas Medical Center, Kansas City, MO. 5. Division of Vascular and Endovascular Surgery and the Vascular Center, University of California, Davis Medical Center, Sacramento, CA.
Abstract
BACKGROUND: To evaluate the efficacy of endovascular therapy for maintaining patency and preserving limbs among patients with failing infrapopliteal bypass grafts. METHODS: We gathered data from a registry of catheter-based procedures for peripheral artery disease. Of 1554 arteriograms performed from 2006 to 2012, 30 patients had interventions for failing bypass vein grafts to infrapopliteal target vessels. The first intervention for each patient was used in this analysis. Duplex ultrasonography was used within 30 days after intervention and subsequently at 3- to 6-month intervals for graft surveillance. RESULTS: Interventions were performed for duplex ultrasonography surveillance findings in 21 patients and for symptoms of persistent or recurrent critical limb ischemia in 9 patients. Procedural techniques included cutting balloon angioplasty (83%), conventional balloon angioplasty (7%), and stent placement (10%). Procedural success was achieved in all cases. There were no procedure-related complications, amputations, or deaths within 30 days. By Kaplan-Meier analysis, 37% of the patients were free from graft restenosis at 12 months and 31% were at 24 months. Receiver-operating characteristic analysis indicated that a lesion length of 1.75 cm best predicted freedom from restenosis (C statistic: 0.74). Residual stenosis (P = 0.03), patency without reintervention (P = 0.01), and assisted patency with secondary intervention (P = 0.02) rates were superior for short lesions compared with long lesions. The cohort had acceptable rates of adverse clinical outcomes, with 96% of patients free from amputation at both 12 and 24 months; clinical outcomes were also better in patients with short lesions. CONCLUSIONS: In this single-center experience with endovascular therapies to treat failing infrapopliteal bypass grafts, rates of limb preservation were high, but the majority of patients developed graft restenosis within 12 months. Grafts with longer stenoses fared poorly by comparison. These data suggest that endovascular interventions to restore or prolong graft patency may be associated with maintained graft patency and that close follow-up with vascular laboratory surveillance is essential. Published by Elsevier Inc.
BACKGROUND: To evaluate the efficacy of endovascular therapy for maintaining patency and preserving limbs among patients with failing infrapopliteal bypass grafts. METHODS: We gathered data from a registry of catheter-based procedures for peripheral artery disease. Of 1554 arteriograms performed from 2006 to 2012, 30 patients had interventions for failing bypass vein grafts to infrapopliteal target vessels. The first intervention for each patient was used in this analysis. Duplex ultrasonography was used within 30 days after intervention and subsequently at 3- to 6-month intervals for graft surveillance. RESULTS: Interventions were performed for duplex ultrasonography surveillance findings in 21 patients and for symptoms of persistent or recurrent critical limb ischemia in 9 patients. Procedural techniques included cutting balloon angioplasty (83%), conventional balloon angioplasty (7%), and stent placement (10%). Procedural success was achieved in all cases. There were no procedure-related complications, amputations, or deaths within 30 days. By Kaplan-Meier analysis, 37% of the patients were free from graft restenosis at 12 months and 31% were at 24 months. Receiver-operating characteristic analysis indicated that a lesion length of 1.75 cm best predicted freedom from restenosis (C statistic: 0.74). Residual stenosis (P = 0.03), patency without reintervention (P = 0.01), and assisted patency with secondary intervention (P = 0.02) rates were superior for short lesions compared with long lesions. The cohort had acceptable rates of adverse clinical outcomes, with 96% of patients free from amputation at both 12 and 24 months; clinical outcomes were also better in patients with short lesions. CONCLUSIONS: In this single-center experience with endovascular therapies to treat failing infrapopliteal bypass grafts, rates of limb preservation were high, but the majority of patients developed graft restenosis within 12 months. Grafts with longer stenoses fared poorly by comparison. These data suggest that endovascular interventions to restore or prolong graft patency may be associated with maintained graft patency and that close follow-up with vascular laboratory surveillance is essential. Published by Elsevier Inc.
Authors: M Adamian; A Colombo; C Briguori; T Nishida; F Marsico; C Di Mario; R Albiero; I Moussa; J W Moses Journal: J Am Coll Cardiol Date: 2001-09 Impact factor: 24.094
Authors: T Muramatsu; R Tsukahara; M Ho; Y Ito; K Hirano; H Ishimori; M Matushita; M Nakano Journal: J Invasive Cardiol Date: 2001-06 Impact factor: 2.022
Authors: Laura Mauri; Raoul Bonan; Bonnie H Weiner; Victor Legrand; Jean-Pierre Bassand; Jeffrey J Popma; Paulette Niemyski; Ross Prpic; Kalon K L Ho; Manish S Chauhan; Donald E Cutlip; Olivier F Bertrand; Richard E Kuntz Journal: Am J Cardiol Date: 2002-11-15 Impact factor: 2.778
Authors: H K Söder; H I Manninen; P Jaakkola; P J Matsi; H T Räsänen; E Kaukanen; P Loponen; S Soimakallio Journal: J Vasc Interv Radiol Date: 2000-09 Impact factor: 3.464
Authors: G A Tannenbaum; F B Pomposelli; E J Marcaccio; G W Gibbons; D R Campbell; D V Freeman; A Miller; F W LoGerfo Journal: J Vasc Surg Date: 1992-06 Impact factor: 4.268
Authors: Niten Singh; Anton N Sidawy; Kent J DeZee; Richard F Neville; Cameron Akbari; William Henderson Journal: J Vasc Surg Date: 2008-03 Impact factor: 4.268